Category: Pharma News

Laevoroc’s LR 09 is given orphan medication classification by the US FDA to treat leukaemia relapse following allogeneic stem cell transplant.

LR 09, a novel metabolic immune checkpoint inhibitor, has been given Orphan Drug Designation by the US Food and Drug Administration (FDA) for the treatment of patients with haematological malignancies who have been identified with a relapse following allogeneic stem…

In order to treat AS and RA, Enzene Biosciences has started selling biosimilar adalimumab commercially in India.

Adalimumab has started to be sold commercially for the treatment of rheumatoid arthritis and ankylosing spondylitis, according to Enzene Biosciences Ltd., a technology-focused biotechnology business based in Pune. This is the business’s fourth biosimilar launch in recent years, and the…

At one year in the ADAPT research, the MiniMed 780G system outperforms numerous daily injections with CGM for the management of type 1 diabetes.

The performance of the MiniMed 780G advanced hybrid closed loop system (AHCL) versus multiple daily insulin injections (MDI) with an intermittently scanned CGM was compared in the first multi-national randomised controlled study, or “ADAPT,” conducted by Medtronic plc, the world…

IISc researchers develop novel brain imaging technology to find cell components that are now undetectable to microscopes.

Researchers from the Indian Institute of Science (IISc), Bengaluru demonstrate how a brain-inspired image sensor can identify minute items like cellular components or nanoparticles that are undetectable to modern microscopes by going beyond the diffraction limit of light. Their ground-breaking…

To accelerate the research and development of medical devices for commercialization, the ICMR has shortlisted three companies for the mPRiDE initiative.

The Product Ignition & Development Enabler (mPRiDE) programme of the Indian Council of Medical Research (ICMR) has shortlisted three companies: Udyog Yantra Technologies Pvt Ltd, LVP Eye Innovations, Hyderabad, and Evelabs Technologies Pvt Ltd, Kollam. The programme aims to accelerate…

ICMR has issued an invitation to makers of vaccines to formulate a vaccine against Kyasanur Forest Disease

The Kyasanur Forest Disease Vaccine (KFDV) isolate will be used in R&D activities by experienced vaccine manufacturers, pharmaceutical corporations, and research and development organisations for the development of a vaccine against KFD and its manufacture or commercialization. In order to…

Back to top
WhatsApp Join Telegram